| Autor: |
Ayers AT; Diabetes Technology Society, Burlingame, CA, USA., Ho CN; Diabetes Technology Society, Burlingame, CA, USA., Wong JC; Division of Endocrinology, Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA., Kerr D; Center for Health Systems Research, Sutter Health, Santa Barbara, CA, USA., Mader JK; Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Klonoff DC; Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USA. |
| Jazyk: |
angličtina |
| Zdroj: |
Journal of diabetes science and technology [J Diabetes Sci Technol] 2024 Oct 12, pp. 19322968241288923. Date of Electronic Publication: 2024 Oct 12. |
| DOI: |
10.1177/19322968241288923 |
| Abstrakt: |
Competing Interests: Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: A.T.A. is a consultant for Liom.C.N.H. is a consultant for Liom.J.C.W. has nothing to disclose.D.K. has received research funding from Abbott Diabetes Care.J.K.M. is a member in the advisory boards of Abbott Diabetes Care, Becton-Dickinson/Embecta, Biomea, Eli Lilly, Medtronic, Novo Nordisk, Pharmasens, Roche Diabetes Care, Sanofi and Viatris, received speaker honoraria from Abbott Diabetes Care, A. Menarini Diagnostics, Becton-Dickinson/Embecta, Boehringer-Ingelheim, Eli Lilly, MedTrust, Novo Nordisk, Roche Diabetes Care, Sanofi, Servier and Ypsomed and is shareholder of decide Clinical Software GmbH and elyte Diagnostics.DC.K. is a consultant for Afon, Atropos Health, embecta, Glucotrack, Lifecare, Novo, Samsung, Synchneuro, and Thirdwayv. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
